William Blair analyst Y. Katherine Xu remains on the sidelines with shares of Tokai Pharmaceuticals, Inc.
William Blair analysts John Sonnier and Y Katherine Xu issued a note to investors on August 26 highlighting their best investment ideas in …
Biotechnology companies release data on pipeline drug studies up update analysts and investors on the progress of a drug. Positive data releases have …
In a research report released Friday, William Blair analyst Y Katherine Xu reiterated an Outperform rating on Synthetic Biologics Inc (NYSEMKT:SYN) with a $12 …
William Blair analyst Y Katherine Xu came out with a favorable report on Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), after the company announced updated clinical data on its investigational …
In a research report released today, William Blair analyst Y Katherine Xu maintained an Outperform rating on Oncogenex (NASDAQ:OGXI), but reduced her price target …
In a research report issued today, William Blair analyst Katherine Xu maintained an Outperform rating on Dynavax Tech. (NASDAQ:DVAX) with a $4 price …
In a research note released this morning, William Blair reiterated coverage on Dynavax Technologies Corporation (DVAX) with an Outperform rating and a price target of …
